“…It is the discovery of EPO and its receptor in the nervous and vascular systems that has resulted in great interest and enthusiasm for the potential clinical applications of EPO, such as in Alzheimer's disease, cardiac insufficiency (Assaraf, et al, 2007, Palazzuoli, et al, 2006, and cardiac transplantation (Gleissner, et al, 2006, Mocini, et al, 2007. In the nervous system, the major sites of EPO production and secretion are in the hippocampus, internal capsule, cortex, midbrain, cerebral ECs, and astrocytes (Digicaylioglu, et al, 2004, Genc, et al, 2004. Further work has revealed several other organs as secretory tissues for EPO that include peripheral ECs (Anagnostou, et al, 1994), myoblasts (Ogilvie, et al, 2000), insulin-producing cells (Fenjves, et al, 2003), and cardiac tissue Haller, 2007, Maiese, et al, 2005c).…”